Quantitative Systematic Strategies’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,346
Closed -$2.06M 511
2021
Q1
$2.06M Buy
27,346
+10,797
+65% +$786K 0.32% 85
2020
Q4
$1.13M Buy
+16,549
New +$1.08M 0.16% 211
2020
Q1
Sell
-23,580
Closed -$1.75M 319
2019
Q4
$1.75M Buy
+23,580
New +$1.66M 0.26% 123
2019
Q2
Sell
-4,481
Closed -$242K 491
2019
Q1
$242K Sell
4,481
-7,446
-62% -$460K 0.06% 284
2018
Q4
$781K Buy
+11,927
New +$890K 0.18% 185
2017
Q4
Sell
-9,136
Closed -$743K 571
2017
Q3
$743K Sell
9,136
-179
-2% -$14.2K 0.2% 178
2017
Q2
$748K Buy
9,315
+2,252
+32% +$178K 0.19% 173
2017
Q1
$554K Sell
7,063
-4,367
-38% -$349K 0.16% 196
2016
Q4
$903K Buy
+11,430
New +$925K 0.37% 131
2016
Q3
Sell
-2,293
Closed -$218K 399
2016
Q2
$218K Buy
+2,293
New +$229K 0.1% 263
2015
Q3
Sell
-3,816
Closed -$400K 398
2015
Q2
$400K Buy
+3,816
New +$390K 0.09% 359
2014
Q4
Sell
-8,300
Closed -$664K 345
2014
Q3
$664K Buy
+8,300
New +$654K 0.39% 103

Other funds holding CVS

Quantitative Systematic Strategies's CVS Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of CVS Health (CVS) in Q2 2021, closing a stake of 27,346 shares — an estimated $2.06M sold.

Quantitative Systematic Strategies first reported a position in CVS in Q3 2014 and held it in 12 quarters. The position peaked at $2.06M in Q1 2021. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 27,346 CVS Health shares in Q2 2021, an estimated $2.06M.
  • Quantitative Systematic Strategies first reported a position in CVS Health in Q3 2014 and held it in 12 quarters.
  • Quantitative Systematic Strategies's CVS Health position peaked at $2.06M in Q1 2021.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.